 Jenna Demedis
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Survivors | 7 | 2025 | 279 | 2.020 |
Why?
| | Neoplasms | 12 | 2025 | 2644 | 1.370 |
Why?
| | Sexual Health | 2 | 2024 | 59 | 0.990 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 400 | 0.830 |
Why?
| | Hodgkin Disease | 1 | 2023 | 139 | 0.740 |
Why?
| | Lymphoma | 1 | 2023 | 206 | 0.720 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 288 | 0.630 |
Why?
| | Hyperglycemia | 1 | 2023 | 346 | 0.610 |
Why?
| | Young Adult | 8 | 2025 | 13126 | 0.340 |
Why?
| | Adolescent | 10 | 2025 | 21463 | 0.310 |
Why?
| | Quality of Life | 5 | 2024 | 2868 | 0.260 |
Why?
| | Multicenter Studies as Topic | 2 | 2025 | 307 | 0.260 |
Why?
| | Child | 12 | 2025 | 21968 | 0.240 |
Why?
| | Genetic Heterogeneity | 1 | 2025 | 59 | 0.230 |
Why?
| | Pregnancy, Unplanned | 1 | 2025 | 48 | 0.230 |
Why?
| | Clonal Evolution | 1 | 2025 | 45 | 0.230 |
Why?
| | Medical Oncology | 2 | 2024 | 290 | 0.220 |
Why?
| | Survivorship | 1 | 2025 | 49 | 0.220 |
Why?
| | Febrile Neutropenia | 1 | 2023 | 6 | 0.220 |
Why?
| | Mixed Tumor, Malignant | 1 | 2023 | 5 | 0.210 |
Why?
| | Sarcoma, Ewing | 1 | 2025 | 95 | 0.210 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2024 | 65 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 117 | 0.210 |
Why?
| | Symptom Assessment | 1 | 2024 | 125 | 0.210 |
Why?
| | Adipose Tissue, Brown | 1 | 2023 | 53 | 0.210 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2023 | 135 | 0.200 |
Why?
| | Bone Neoplasms | 1 | 2025 | 248 | 0.200 |
Why?
| | Urinary Tract | 1 | 2023 | 51 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 77 | 0.190 |
Why?
| | Patients | 1 | 2024 | 173 | 0.190 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 310 | 0.190 |
Why?
| | Testicular Neoplasms | 1 | 2023 | 110 | 0.190 |
Why?
| | Positron-Emission Tomography | 1 | 2023 | 295 | 0.190 |
Why?
| | Rhabdoid Tumor | 1 | 2023 | 99 | 0.180 |
Why?
| | Bacterial Infections | 1 | 2023 | 251 | 0.180 |
Why?
| | Bacteremia | 1 | 2023 | 209 | 0.180 |
Why?
| | Humans | 17 | 2025 | 136783 | 0.180 |
Why?
| | Adult | 7 | 2025 | 37616 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2025 | 543 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1043 | 0.150 |
Why?
| | Overweight | 1 | 2023 | 557 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1274 | 0.140 |
Why?
| | Glucose | 1 | 2023 | 1019 | 0.140 |
Why?
| | Sepsis | 1 | 2023 | 611 | 0.140 |
Why?
| | Health Promotion | 1 | 2023 | 736 | 0.130 |
Why?
| | Incidence | 1 | 2023 | 2788 | 0.130 |
Why?
| | Qualitative Research | 1 | 2023 | 1359 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1294 | 0.120 |
Why?
| | Mass Screening | 1 | 2024 | 1262 | 0.120 |
Why?
| | Female | 9 | 2025 | 72840 | 0.120 |
Why?
| | Retrospective Studies | 2 | 2023 | 15564 | 0.120 |
Why?
| | Primary Health Care | 1 | 2025 | 1714 | 0.110 |
Why?
| | Male | 7 | 2025 | 67361 | 0.110 |
Why?
| | Risk Factors | 2 | 2025 | 10331 | 0.100 |
Why?
| | Blood Glucose | 1 | 2023 | 2180 | 0.100 |
Why?
| | Infant | 2 | 2023 | 9442 | 0.090 |
Why?
| | Child, Preschool | 2 | 2025 | 11069 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2108 | 0.090 |
Why?
| | Anti-Bacterial Agents | 3 | 2025 | 1799 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 2975 | 0.080 |
Why?
| | Prognosis | 2 | 2025 | 4018 | 0.060 |
Why?
| | Equivalence Trials as Topic | 1 | 2025 | 8 | 0.060 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2025 | 80 | 0.060 |
Why?
| | Critical Pathways | 1 | 2024 | 89 | 0.050 |
Why?
| | Fatigue | 1 | 2024 | 327 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 451 | 0.050 |
Why?
| | Fever | 1 | 2023 | 307 | 0.050 |
Why?
| | Fertility | 1 | 2023 | 159 | 0.050 |
Why?
| | Prospective Studies | 2 | 2025 | 7583 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 671 | 0.040 |
Why?
| | Self Report | 1 | 2024 | 825 | 0.040 |
Why?
| | Interpersonal Relations | 1 | 2023 | 404 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2025 | 760 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 487 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1396 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1768 | 0.040 |
Why?
| | Communication | 1 | 2023 | 869 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1568 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 847 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5115 | 0.030 |
Why?
| | Hospitalization | 1 | 2023 | 2195 | 0.030 |
Why?
| | Pregnancy | 1 | 2025 | 6731 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 5749 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6046 | 0.020 |
Why?
| | Middle Aged | 1 | 2023 | 33200 | 0.010 |
Why?
|
|
Demedis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|